Design News Direct and Packaging Digest Direct are part of the Informa Markets Division of Informa PLC
Informa PLC
ABOUT US
INVESTOR RELATIONS
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
TissueGen® Inc. provides medical device developers with cutting-edge absorbable polymer technology for implantable drug delivery. Our patented process enables fiber extrusion at room temperature with drugs and therapeutic agents previously impossible to incorporate in implant devices. In more way...
TissueGen® Inc. provides medical device developers with cutting-edge absorbable polymer technology for implantable drug delivery. Our patented process enables fiber extrusion at room temperature with drugs and therapeutic agents previously impossible to incorporate in implant devices. In more ways than ever, device developers can now take advantage of drug delivery through our ELUTE® biodegradable drug-loaded fiber an incredible breakthrough that drastically expands the variety of biologics to be delivered via implant.
TissueGen
T: 214-351-1922
Address
2110 Research Row
Suite 303
Dallas, TX
75235
United States
View map
TissueGen
T: 214-351-1922
Address
2110 Research Row
Suite 303
Dallas, TX
75235
United States
View map